PULMONARY SARCOIDOSIS
Clinical trials for PULMONARY SARCOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new PULMONARY SARCOIDOSIS trials appear
Sign up with your email to follow new studies for PULMONARY SARCOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets lung inflammation in sarcoidosis
Disease control Recruiting nowThis study is testing whether a new oral drug called OATD-01 can help control active lung sarcoidosis. About 96 adults with symptomatic lung sarcoidosis will take either the drug or a placebo pill for 12 weeks. Researchers will use special scans to see if the drug reduces lung in…
Matched conditions: PULMONARY SARCOIDOSIS
Phase: PHASE2 • Sponsor: Molecure S.A. • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
New drug trial aims to tame sarcoidosis and cut steroid dependence
Disease control Recruiting nowThis study is testing a new drug called XTMAB-16 for adults with pulmonary sarcoidosis, a disease that causes inflammation and scarring in the lungs. The main goals are to see if the drug is safe and if it can help patients reduce their daily dose of steroid medications, which of…
Matched conditions: PULMONARY SARCOIDOSIS
Phase: PHASE1, PHASE2 • Sponsor: Xentria, Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Scientists hunt for genetic clues behind common lung diseases
Knowledge-focused Recruiting nowThis study aims to understand how genes contribute to the development of various lung diseases, including cystic fibrosis, asthma, and pulmonary fibrosis. Researchers will collect genetic information from up to 3,500 participants, including people with these conditions and health…
Matched conditions: PULMONARY SARCOIDOSIS
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC